Savran Technologies Inc. presented new data on early prediction of preeclampsia at the Society for Reproductive Investigation Annual Meeting (SRI 2026), where its work was selected for oral presentation; an honor awarded to a small fraction of submissions.

The presentation highlighted the company’s non-invasive, urine-based diagnostic approach, designed to detect  preeclampsia well before clinical symptoms appear. This enables prediction months in advance, creating a window for earlier intervention and improved outcomes.

About the SRI Annual Scientific Meeting

The Society for Reproductive Investigation (SRI) Annual Scientific Meeting is a premier international conference bringing together leading researchers and clinicians in reproductive biology, maternal–fetal medicine, and women’s health. The meeting highlights high-impact translational and clinical research shaping the future of reproductive and pregnancy care.